These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10744168)

  • 1. Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease.
    Caimi G; Canino B; Romano A; Catania A; Lo Presti R
    Thromb Haemost; 2000 Mar; 83(3):516-7. PubMed ID: 10744168
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte membrane fluidity and red cell cytosolic Ca2+ content during incubation, in normals and in subjects with vascular atherosclerotic disease and non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Lo Presti R
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):195-7. PubMed ID: 9699042
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocyte individual phospholipids and erythrocyte membrane fluidity in subjects with vascular atherosclerotic disease with and without diabetes mellitus of type 2.
    Caimi G; Serra A; Catania A; D'Asaro S; Montana M; Lo Presti R; Sarno A
    Microcirc Endothelium Lymphatics; 1990; 6(2-3):149-57. PubMed ID: 2247023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane fluidity in non-insulin-dependent diabetes mellitus (NIDDM) subjects, in subjects with vascular atherosclerotic disease (VAD) and in VAD subjects with NIDDM.
    Caimi G; Canino B; Montana M; Catania A; Lo Presti R
    Thromb Haemost; 1999 Jul; 82(1):149. PubMed ID: 10456470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erythrocyte aggregation, erythrocyte filterability and membrane fluidity in single-area atherosclerotic vascular disease].
    Sarno A; Serra A; Catania A; Francavilla G; Lo Presti R; Caimi G
    Ric Clin Lab; 1989; 19 Suppl 1():133-6. PubMed ID: 2629073
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus.
    Caimi G; Lo Presti R; Montana M; Carollo C; Amodeo G; Romano A; Canino B
    Clin Hemorheol Microcirc; 2004; 30(3-4):229-35. PubMed ID: 15258348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte flow properties, polymorphonuclear membrane fluidity, and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease with and without noninsulin-dependent diabetes mellitus.
    Caimi G; Canino B; Ferrara F; Montana M; Meli F; Catania A; Lo presti R
    Angiology; 1996 Aug; 47(8):757-63. PubMed ID: 8712478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the erythrocytes in the etiology of vascular lesions in diabetes mellitus].
    Kharash LM; Lapotnikov VA
    Ter Arkh; 1982; 54(10):24-7. PubMed ID: 7179115
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations of erythrocyte insulin receptor and membrane microviscosity of erythrocyte in type II diabetics].
    Zhang WR; He DH; Zhu XX; Zhong XL; Pan XP; Tao HG; Zhou YP
    Sheng Li Xue Bao; 1988 Oct; 40(5):518-22. PubMed ID: 3251364
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavior of the polymorphonuclear leukocyte membrane fluidity and cystolic Ca2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Ferrara F; Ventimiglia G; Meli F; Romano A; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(6):429-36. PubMed ID: 9502527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal thiol group modulation of sodium-lithium countertransport and membrane fluidity is associated with a disturbed relationship between serum triacylglycerols and membrane function in type II diabetes.
    Senior PA; Thomas TH; Marshall SM
    Clin Sci (Lond); 2000 Jun; 98(6):673-80. PubMed ID: 10814604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of thrombocytes and plasma for the regulation of hemostasis in type II diabetics].
    Sinzinger H; Fitscha P
    Vasa; 1985; 14(2):121-4. PubMed ID: 4013489
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoproteins as risk factors for vascular disease in diabetes.
    Brown WV; Bloomgarden Z; Ginsberg H
    Mt Sinai J Med; 1982; 49(3):176-86. PubMed ID: 6981757
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemorheological alteration in diabetes].
    Uchimura I; Maezawa H
    Nihon Rinsho; 1990 Dec; 48 Suppl():752-60. PubMed ID: 2086956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythrocyte lipids in diabetes mellitus with vascular involvement].
    Kasimova GM; Mirtalipov DT; Abidov AA; Akbarov ZS
    Vopr Med Khim; 1989; 35(3):42-7. PubMed ID: 2773383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.